WNS Triange Powers Business Growth & Innovation with Next-gen Data & Analytics Solutions and Artificial Intelligence

NEW YORK & LONDON & MUMBAI, India--(BUSINESS WIRE)--#AI--WNS (Holdings) Limited (NYSE: WNS), a leading provider…

Ranok Therapeutics to Present at BMO Biopharma Spotlight Series on Protein Degraders and Other Next Gen Technologies

--CSO Kevin Foley to highlight FDA IND clearance for Ranok’s first clinical program, RNK05047, that…

Expo Bazaar USA — Digital B2B Marketplace for Retailers Seeking Artisanal Home Products From India — To Launch in March 2022

The first-of-its-kind online service connects independent specialty stores and designers with handicrafts, gifts and home…

Japan Gift Card and Incentive Card Market Report 2022: Market is Expected to Grow by 10.7% to Reach $20,188.0 Million in 2022 – Forecast to 2026 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Japan Gift Card and Incentive Card Market Intelligence and Future Growth Dynamics (Databook)…

Japan Gift Card and Incentive Card Market Report 2022: Market is Expected to Grow by 10.7% to Reach $20,188.0 Million in 2022 – Forecast to 2026 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Japan Gift Card and Incentive Card Market Intelligence and Future Growth Dynamics (Databook)…

Japan Gift Card and Incentive Card Market Report 2022: Market is Expected to Grow by 10.7% to Reach $20,188.0 Million in 2022 – Forecast to 2026 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Japan Gift Card and Incentive Card Market Intelligence and Future Growth Dynamics (Databook)…

ValenzaBio and Novelty Nobility Announce Exclusive License Agreement for Potential Best-in-Class Anti-c-KIT Monoclonal Antibody

BETHESDA, Md. & PANGYO, South Korea--(BUSINESS WIRE)--ValenzaBio, Inc., a biopharmaceutical company developing monoclonal antibody (mAb)…

ValenzaBio and Novelty Nobility Announce Exclusive License Agreement for Potential Best-in-Class Anti-c-KIT Monoclonal Antibody

BETHESDA, Md. & PANGYO, South Korea--(BUSINESS WIRE)--ValenzaBio, Inc., a biopharmaceutical company developing monoclonal antibody (mAb)…

ValenzaBio and Novelty Nobility Announce Exclusive License Agreement for Potential Best-in-Class Anti-c-KIT Monoclonal Antibody

BETHESDA, Md. & PANGYO, South Korea--(BUSINESS WIRE)--ValenzaBio, Inc., a biopharmaceutical company developing monoclonal antibody (mAb)…

JCR Pharmaceuticals’ Research Presentations at WORLDSymposium™ 2022 Showcase JR-141 (Pabinafusp Alfa) and Other Investigational Treatments for Lysosomal Storage Disorders

- Presentations Highlight Potential Benefits of Therapies Incorporating J-Brain Cargo®, JCR’s Proprietary, Blood-Brain Barrier-Penetrating Technology…